This is a non-core endpoint: only basic statistics are computed.
Melanoma in situ of trunk
CD2_INSITU_MELANOMA_TRUNK_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D03
- Name in latin
- Melanoma in situ trunci
Similar endpoints
↥List of similar endpoints to
Melanoma in situ of trunk
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ of trunk
- Melanoma in situ
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 433 | 161 | 272 |
| Unadjusted period prevalence (%) | 0.10 | 0.05 | 0.12 |
| Median age at first event (years) | 69.20 | 65.60 | 71.33 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 371
- Matched controls
- 3710
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.5
ICD-10 Finland
Melanoma in situ of trunk
+∞
323.0
371
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
181.6
293.7
290
71
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
35.6
108.9
143
64
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
82.4
76
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
15.2
78.1
140
142
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
856.2
73.8
70
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
296.5
73.2
72
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
23.3
73.2
108
64
L57.0
ICD-10 Finland
Actinic keratosis
12.1
64.9
129
156
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
19.4
64.2
101
70
PJA12
NOMESCO Finland
Sentinel node biopsy
653.8
58.3
56
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
51.2
48
*
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
20.9
50.3
76
45
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
196.3
50.2
51
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
49.0
46
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
45.8
43
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
6.5
41.8
125
269
130
Kela drug reimbursment
Malignant tumour
+∞
39.3
37
*
S18
ICPC
Laceration/cut
4.3
38.8
242
1120
TQW99
NOMESCO Finland
Other minor procedure on skin
15.2
37.3
63
49
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
37.1
35
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
37.1
35
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
22.7
36.5
53
27
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
34.9
33
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
33.9
32
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
19.5
31.5
48
28
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
41.3
27.6
34
9
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
27.4
26
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
27.4
26
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
19.3
26.4
40
23
ZZR00
NOMESCO Finland
Flap of skin
38.7
25.6
32
9
115
Kela drug reimbursment
Breast cancer
+∞
25.3
24
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
25.3
24
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
23.2
22
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
29.5
22.6
30
11
ZXC50
NOMESCO Finland
Cryotherapy
18.6
22.2
34
20
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
+∞
22.1
21
*
116
Kela drug reimbursment
Prostate cancer
+∞
22.1
21
*
S77
ICPC
Malignant neoplasm of skin
+∞
22.1
21
*
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
85.4
21.9
24
*
L82
ICD-10 Finland
Seborrhoeic keratosis
3.9
21.9
104
337
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
21.0
20
*
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
+∞
21.0
20
*
SPAT1153
SPAT
Removal of sutures
3.0
20.9
175
859
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
20.0
19
*
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
+∞
20.0
19
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
24.1
19.3
27
12
8720/2-C44.5
ICD-O-3
Melanoma in situ of skin of trunk
+∞
18.9
18
*
S82
ICPC
Naevus/mole
4.1
18.7
81
239
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
21.4
18.0
26
13
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
17.8
17
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
17.8
17
*
JN4BD
NOMESCO Finland
Extensive body CT
5.8
17.5
51
99
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
16.8
16
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
16.8
16
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
16.8
16
*
WF002
NOMESCO Finland
Radical radiotherapy
94.3
16.7
18
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
15.7
15
*
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
23.3
15.7
22
10
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
19.4
14.9
22
12
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
83.4
14.7
16
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
14.7
14
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
14.7
14
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
14.7
14
*
L02BG04
ATC
letrozole; oral
155.8
14.6
15
*
L02AE02
ATC
leuprorelin; implant, parenteral
31.4
14.0
18
6
ZQZ00
NOMESCO Finland
Treatment of several skin areas
55.5
13.9
16
*
H02AB02
ATC
dexamethasone; systemic
13.5
13.6
23
18
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
13.6
122
589
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
29.6
13.1
17
6
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
+∞
12.6
12
*
8743/3-C44.5
ICD-O-3
Low cumulative sun damage melanoma of skin of trunk
+∞
12.6
12
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
12.6
12
*
Z2221
NOMESCO Finland
Medical doctor
2.5
12.3
119
593
D06BB10
ATC
imiquimod; topical
6.1
12.3
33
58
ZXC20
NOMESCO Finland
Use of chemical agents
14.0
12.1
20
15
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
48.3
12.0
14
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.1
11.7
37
79
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
67.1
11.7
13
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
11.5
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
+∞
11.5
11
*
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
123.6
11.5
12
*
N02BE01
ATC
paracetamol; systemic, rectal
2.6
10.8
322
2646
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
61.8
10.7
12
*
D22
ICD-10 Finland
Melanocytic naevi
6.1
10.5
28
49
L02BB03
ATC
bicalutamide; oral
113.0
10.5
11
*
L02BA01
ATC
tamoxifen; oral
113.0
10.5
11
*
180
Kela drug reimbursment
Interferon alfa
+∞
10.5
10
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
10.5
10
*
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
+∞
10.5
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.5
10
*
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
+∞
10.5
10
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
10.5
10
*
XQ845
NOMESCO Finland
Dermatoscopy
12.5
10.5
18
15
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
11.1
10.4
19
18
S29
ICPC
Skin symptom/complaint other
2.5
9.9
83
378
HAB40
NOMESCO Finland
Wedge excision of mammary gland
56.5
9.7
11
*
XQ848
NOMESCO Finland
Dermatological photography
6.9
9.6
23
35
Y77
ICPC
Malignant neoplasm prostate
+∞
9.4
9
*
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
9.4
9
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
9.4
9
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
9.4
9
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
9.4
9
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
6.3
9.4
24
40
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
11.1
9.4
17
16
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
7.8
9.0
20
27
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
24.7
9.0
12
5
ZXC15
NOMESCO Finland
Use of photodynamic technique
24.7
9.0
12
5
S26
ICPC
Fear of cancer of skin
16.8
8.6
13
8
Z31.5
ICD-10 Finland
Genetic counselling
8.2
8.5
18
23
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.2
8.5
18
23
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
11.1
8.4
15
14
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
8.4
8
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
8.4
8
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
L01BC06
ATC
capecitabine; oral
+∞
8.4
8
*
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
+∞
8.4
8
*
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
+∞
8.4
8
*
ZXE00
NOMESCO Finland
One hour or less
2.0
8.1
144
905
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
8.1
137
847
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
8.0
97
524
A03FA01
ATC
metoclopramide; systemic, rectal
2.8
8.0
53
209
S21
ICPC
Skin texture symptom/complaint
2.7
7.9
56
231
XKD00
NOMESCO Finland
Uroflowmetry
2.3
7.9
84
426
JN4AD
NOMESCO Finland
Body CT examination
4.8
7.8
25
55
HA1AA
NOMESCO Finland
X-ray mammography
6.4
7.6
19
31
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.1
7.6
94
510
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
25.6
7.6
10
*
WX110
NOMESCO Finland
Local anesthesy
1.9
7.5
240
1842
WZC30
NOMESCO Finland
Teaching
2.7
7.5
50
199
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
81.6
7.4
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
81.6
7.4
8
*
A98
ICPC
Health maint/preventive medicine
3.1
7.4
351
3155
Z51.5
ICD-10 Finland
Palliative care
5.6
7.3
20
37
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
7.3
7
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
+∞
7.3
7
*
8742/2-C44.5
ICD-O-3
Lentigo maligna of skin of trunk
+∞
7.3
7
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
7.3
7
*
8742/3-C44.9
ICD-O-3
Lentigo maligna melanoma of skin, NOS
+∞
7.3
7
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
7.3
7
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
7.3
7
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
7.3
7
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.4
6.9
24
58
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
9.6
6.8
13
14
E0000UV
ATC
NA
1.9
6.8
137
889
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
17.1
6.8
10
6
J01DB01
ATC
cefalexin; oral
1.9
6.6
292
2438
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.2
6.6
68
339
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
6.5
69
348
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
71.0
6.4
7
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
71.0
6.4
7
*
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
14.6
6.4
10
7
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
6.3
6
*
1509
Kela drug reimbursment
Dabrafenib (adjuvant treatment)
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
L01XE23
ATC
[U] dabrafenib; oral
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
C44
ICD-10 Finland
Other malignant neoplasms of skin
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
6.3
6
*
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
+∞
6.3
6
*
3024
Kela drug reimbursment
Dabrafenib and trametinib (adjuvant treatment)
+∞
6.3
6
*
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
+∞
6.3
6
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
27.2
6.2
8
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
27.2
6.2
8
*
R4110
NOMESCO Finland
Physiotherapy
1.9
6.2
93
543
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
12.8
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
227
256
17.54
203.41
2.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
345
1011
12.87
134.07
4.7
1.6
—
—
—
0
0
(4035726)
110
90
16.04
115.81
1.5
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
65
136
5.45
30.33
1.4
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
65
205
3.55
17.51
4.2
1.5
ug/l
4.6
4.2
0.09
54
161
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
399
3277
3.77
13.95
20.7
12.4
ml/min/173m2
74.7
75.2
0.21
345
2660
(3044640) Blood type and Crossmatch panel - Blood
173
999
2.22
13.93
2.6
2.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
251
1703
2.13
13.08
8.0
3.8
umol/l
11.2
12.2
0.98
233
1599
(40758558) Short blood count panel - Blood
137
746
2.22
12.52
6.8
4.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
179
1084
2.11
12.45
6.2
5.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
342
2653
2.38
12.29
9.9
5.2
u/l
80.5
76.1
0.62
320
2438
(3015377) Calcium [Moles/volume] in Serum or Plasma
186
1148
2.09
12.25
4.9
2.1
mmol/l
2.3
2.4
0.16
159
939
(3018095) Leukocytes [#/volume] in Urine
193
1240
2.00
11.10
4.6
3.5
e6/l
98.8
78.6
0.21
139
886
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
404
3448
3.56
11.08
18.2
13.4
mg/l
22.5
25.1
0.96
336
2691
(3033658) Prothrombin time (PT) actual/Normal
142
819
2.09
10.98
4.3
3.5
%
85.0
84.6
0.07
137
800
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
162
987
2.02
10.74
3.7
2.7
ug/l
0.8
0.8
0.11
115
673
(3002582) Erythrocytes [#/volume] in Urine
173
1079
2.00
10.74
3.8
3.0
e6/l
21.4
125.3
1.03
132
828
(3013650) Neutrophils [#/volume] in Blood by Automated count
254
1813
1.97
10.59
10.8
6.0
e9/l
3.9
4.4
2.63
211
1579
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
420
3707
5.43
10.29
13.7
9.1
u/l
25.4
25.5
0.02
401
3547
(3021589) Normoblasts [#/volume] in Blood
216
1479
1.92
9.99
11.7
8.2
e9/l
0.0
0.0
0.64
171
1218
(3031040) Bacteria [#/volume] in Urine by Automated count
297
2266
1.99
9.86
4.5
4.3
e6/l
5687.0
2194.7
—
8
43
(3022096) Basophils/100 leukocytes in Blood
212
1470
1.87
9.19
7.3
5.2
%
0.7
0.7
0.16
189
1356
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
38
5.18
9.17
1.4
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
18
7.41
8.89
1.5
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
216
1520
1.84
8.81
7.1
5.2
%
2.9
3.0
0.47
194
1396
(40768800) Prostate Pathology biopsy report
15
25
6.18
8.71
1.4
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
216
1525
1.83
8.68
7.3
5.5
%
9.0
8.8
0.30
196
1410
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
223
1594
1.82
8.56
5.9
5.3
mmol/l
1.2
1.2
0.56
191
1410
(3030467) Casts [#/volume] in Urine by Automated count
154
983
1.88
8.51
3.8
2.8
e6/l
0.7
0.5
0.33
114
731
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
238
1741
1.81
8.41
6.4
5.8
mmol/l
1.2
1.2
0.01
193
1498
(3018010) Neutrophils/100 leukocytes in Blood
216
1538
1.81
8.33
6.8
5.2
%
58.9
57.9
0.59
195
1426
(3002030) Lymphocytes/100 leukocytes in Blood
217
1552
1.80
8.20
7.3
5.3
%
26.2
26.7
0.28
197
1427
(40768795) Lymph node Pathology biopsy report
10
11
9.28
8.11
1.1
1.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
414
3703
3.69
8.11
23.1
15.9
umol/l
85.1
82.9
0.57
414
3703
(36304419) Bacteria [Presence] in Urine
147
938
1.86
8.05
3.7
2.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
422
3829
5.02
7.93
28.1
19.8
e9/l
239.1
238.1
0.12
414
3714
(3024731) MCV [Entitic volume]
422
3830
5.01
7.90
28.0
19.8
fl
91.6
91.6
0.07
416
3758
(3035941) MCH [Entitic mass]
422
3830
5.01
7.90
28.0
19.7
pg
30.4
30.5
0.48
416
3758
(3026361) Erythrocytes [#/volume] in Blood
422
3831
5.00
7.88
28.1
19.8
e12/l
4.5
4.5
0.53
412
3698
(3013115) Eosinophils [#/volume] in Blood
232
1706
1.78
7.86
6.9
5.1
e9/l
0.2
0.2
0.59
189
1486
(3010813) Leukocytes [#/volume] in Blood
422
3832
4.99
7.85
28.1
19.9
e9/l
6.7
6.8
0.05
412
3703
(3000963) Hemoglobin [Mass/volume] in Blood
422
3832
4.99
7.85
28.3
20.0
g/l
134.5
136.4
1.80
416
3759
(3000850) Epithelial cells [#/volume] in Urine
122
741
1.90
7.75
3.0
2.2
e6/l
3.5
4.9
1.17
102
639
(3026782) Osmolality of Urine
116
694
1.92
7.71
3.3
2.5
mosm/kgh2o
619.6
551.9
2.71
93
567
(3037467) Urinalysis macro (dipstick) panel - Urine
300
2389
1.83
7.66
4.3
4.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
375
3225
2.22
7.52
5.5
4.4
mu/l
1.9
2.4
0.54
330
2898
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
187
1306
1.76
7.46
3.7
2.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
405
3609
2.89
7.37
16.6
13.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
209
1510
1.74
7.37
6.0
3.7
g/l
35.4
35.3
0.06
195
1388
(3001604) Monocytes [#/volume] in Blood
223
1642
1.74
7.34
6.8
4.9
e9/l
0.6
0.6
0.19
181
1403
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
194
1374
1.75
7.34
2.2
2.2
nmol/l
80.3
78.1
0.53
172
1186
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
7
0
+∞
7.31
1.0
0.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
404
3602
2.82
7.23
5.7
5.5
mmol/l
2.6
2.6
0.13
357
3289
(3032080) INR in Blood by Coagulation assay
212
1545
1.73
7.20
12.0
10.3
inr
1.3
1.4
0.52
61
421
(3006315) Basophils [#/volume] in Blood
223
1650
1.72
7.15
6.8
5.0
e9/l
0.0
0.0
0.01
181
1420
(40768793) Breast Pathology biopsy report
13
23
5.80
7.10
1.2
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
225
1675
1.71
7.01
6.8
5.0
e9/l
1.8
1.8
0.49
187
1460
(3023103) Potassium [Moles/volume] in Serum or Plasma
410
3694
3.07
6.97
22.7
16.7
mmol/l
4.0
4.0
4.28
399
3589
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
396
3513
2.49
6.87
5.2
4.9
mmol/l
4.5
4.5
0.26
354
3225
(3019550) Sodium [Moles/volume] in Serum or Plasma
409
3685
2.98
6.86
22.3
16.6
mmol/l
139.9
139.8
0.32
399
3581
(3018418) pH of Serum or Plasma
148
986
1.76
6.83
4.2
3.2
ph
7.4
7.4
0.72
28
159
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
123
783
1.80
6.59
2.5
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
205
1505
1.69
6.59
4.3
3.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
383
3364
2.20
6.59
4.7
4.4
mmol/l
1.3
1.3
0.10
342
3039
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
392
3478
2.34
6.53
5.2
4.9
mmol/l
1.4
1.4
0.14
350
3167
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
98
584
1.88
6.49
3.4
2.8
e6/l
0.9
2.1
1.78
60
323
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
111
692
1.81
6.35
4.8
2.0
mmol/l
2.5
2.4
1.24
98
587
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
311
2580
1.73
6.06
4.4
3.6
pmol/l
15.1
15.0
0.40
265
2313
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
231
1780
1.64
5.94
6.3
4.1
ug/l
8.5
2.1
0.83
198
1587
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
216
1644
1.63
5.79
2.2
2.1
pmol/l
93.0
93.8
0.09
116
853
(3013707) Erythrocyte sedimentation rate by Westergren method
313
2633
1.68
5.45
4.6
4.0
mm/h
12.4
12.4
0.02
278
2391
(3026493) Urate [Moles/volume] in Serum or Plasma
143
994
1.65
5.43
3.1
2.6
umol/l
5757.2
8245.0
0.18
119
847
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
65
362
1.94
5.23
3.1
3.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
84
511
1.80
5.13
2.9
2.6
mmol/l
0.8
0.8
0.65
74
468
(3013826) Glucose [Moles/volume] in Serum or Plasma
263
2136
1.59
5.12
4.8
4.3
mmol/l
6.6
6.8
1.02
255
1992
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
145
1026
1.62
5.07
2.6
2.7
u/l
35.7
35.2
0.03
138
971
(3000494) Fungus identified in Specimen by Culture
71
412
1.87
5.05
1.4
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
390
3528
2.06
4.96
5.7
5.0
mmol/l
6.0
6.1
0.88
342
3182
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
378
3384
1.92
4.95
6.9
6.6
mmol/mol
40.1
40.9
1.08
340
3117
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
132
919
1.63
4.91
2.4
2.1
mg/l
2.6
3.0
0.82
104
782
(3017446) Testosterone [Moles/volume] in Serum or Plasma
47
245
2.03
4.56
1.8
2.2
nmol/l
12.2
15.1
1.67
40
212
(3002385) Erythrocyte distribution width [Ratio]
321
2771
1.61
4.50
25.6
16.3
%
13.9
13.7
2.11
315
2711
(3020630) Protein [Mass/volume] in Serum or Plasma
53
291
1.94
4.45
2.9
1.6
g/l
64.8
67.3
1.50
48
261
(3008152) Bicarbonate [Moles/volume] in Arterial blood
8
274
0.28
4.42
3.5
6.3
mmol/l
23.8
24.5
—
8
257
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47
248
2.00
4.41
4.1
2.7
mmol/l
1.2
1.2
0.27
37
215
(3052851) Hemolysis interference index of Serum or Plasma
25
101
2.57
4.38
2.4
3.2
—
—
—
0
0
(3044889) 12 lead EKG panel
300
2573
1.54
4.10
4.2
4.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
24
99
2.51
4.04
4.3
1.3
mg/l
40.7
54.0
0.81
19
82
(3045142) Bone marrow Pathology biopsy report
11
28
4.00
4.00
1.0
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
259
2162
1.49
3.97
2.8
3.0
u/l
40.2
48.2
1.93
233
1999
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
24
100
2.48
3.96
4.2
1.3
mg/l
27.9
37.7
1.04
19
84
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
93
624
1.62
3.93
3.2
2.6
e6/l
1.2
1.0
0.12
55
363
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
77
2.67
3.86
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
77
2.67
3.86
1.3
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
15
49
3.14
3.84
1.1
1.3
u/l
8.9
7.0
—
10
43
(3022145) Colonoscopy Study observation
58
344
1.79
3.84
1.4
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
18
66
2.80
3.80
4.5
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
339
3012
1.58
3.73
22.0
15.0
%
38.8
39.7
0.81
236
1955
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
183
1439
1.47
3.71
4.6
4.0
%
21.5
24.4
1.80
103
708
(40761536) Microorganisms panel - Urine sediment
46
258
1.88
3.64
4.2
3.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
177
1388
1.47
3.62
3.1
2.7
ug/l
131.3
139.0
0.22
154
1263
(3003694) ABO and Rh group [Type] in Blood
112
801
1.54
3.58
1.5
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
27
3.77
3.37
1.7
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
27
3.77
3.37
1.8
2.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
32
3.50
3.35
2.2
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
33
171
2.01
3.29
1.3
1.2
iu/ml
65.3
133.5
—
7
74
(3047189) Immunofixation for 24 hour Urine
6
7
8.67
3.27
1.2
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
28
138
2.10
3.19
2.7
1.8
—
—
—
0
0
(3013512) EKG study
151
1173
1.44
3.16
3.9
4.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
70
464
1.61
3.09
3.6
2.2
%
1.8
1.7
0.32
60
417
(3011648) Oxygen content in Venous blood
11
34
3.29
3.08
2.3
1.6
%
8.5
10.4
0.72
11
34
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
12
5.91
3.03
1.9
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
81
2.41
3.03
1.7
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
292
1.72
2.93
1.4
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
59
2.60
2.81
1.1
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
131
1010
1.43
2.80
1.6
1.5
nmol/l
20.4
20.4
0.01
102
862
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
66
2.48
2.74
1.4
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
60
2.55
2.73
2.1
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
154
1228
1.39
2.71
2.3
2.2
u/l
181.8
288.8
0.87
144
1136
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
208
1745
1.37
2.67
2.1
2.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
46
286
1.68
2.61
2.8
2.0
u/l
34.5
32.6
0.15
41
236
(1761868) Lipid panel - Serum or Plasma
144
1144
1.39
2.56
3.4
3.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
28
154
1.87
2.40
1.2
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
71
503
1.49
2.34
5.7
5.1
%
33.3
31.9
0.51
45
333
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
85
2.17
2.32
1.4
1.3
ug/g
271.7
314.9
0.51
12
51
(3018405) Lactate [Moles/volume] in Arterial blood
5
157
0.31
2.31
1.0
3.4
mmol/l
3.9
1.4
—
5
152
(3017143) Hepatitis C virus Ab [Presence] in Serum
43
272
1.64
2.31
1.6
1.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
149
1.87
2.30
2.8
1.3
g/l
6.8
7.6
1.38
20
107
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
149
1.87
2.30
2.8
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
149
1.87
2.30
2.8
1.3
g/l
3.6
3.9
0.56
20
102
(3021788) Differential panel - Synovial fluid
16
73
2.24
2.24
1.2
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
103
790
1.40
2.23
1.7
1.8
nmol/l
1092.0
1183.8
0.43
62
604
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
9
5.60
2.22
1.8
2.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
194
1647
1.32
2.17
3.2
3.7
estimate
0.0
0.0
0.00
42
270
(3019150) Specific gravity of Urine by Refractometry
56
791
0.66
2.16
3.4
4.0
kg/l
1.0
1.0
—
6
119
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
138
1.86
2.14
2.9
1.3
g/l
3.0
3.1
0.18
20
104
(3004588) Protein electrophoresis panel - Serum or Plasma
39
246
1.64
2.13
3.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
110
1.96
2.09
3.6
2.5
u/ml
0.6
0.4
0.87
12
60
(3012441) Differential panel - Pleural fluid
9
31
2.94
2.08
1.4
1.4
—
—
—
0
0
(3020891) Body temperature
6
161
0.36
2.06
1.7
4.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
15
4.04
2.04
1.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
15
4.04
2.04
1.5
2.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
15
4.04
2.04
1.7
1.3
u/l
153.2
192.3
—
6
15
(3023520) Reticulocytes [#/volume] in Blood
51
347
1.53
2.04
3.7
2.3
e9/l
69.4
66.3
0.21
33
279
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
101
786
1.37
1.99
4.4
4.0
ng/l
113.5
337.7
1.55
84
655
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
45
2.48
1.94
2.5
4.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
195
1676
1.30
1.93
3.2
3.6
estimate
0.0
0.0
0.00
42
268
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
43
286
1.56
1.91
3.6
4.2
ng/l
113.6
92.6
0.60
34
251
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
7
22
3.22
1.88
1.0
1.1
mmol/l
1.8
2.1
—
7
22
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
22
122
1.85
1.88
2.0
3.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
19
101
1.92
1.83
1.3
1.6
e6/l
2658.0
17682.5
—
9
76
(3007853) Bacteria identified in Skin by Aerobe culture
57
407
1.46
1.83
1.7
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
12
53
2.30
1.82
1.6
1.6
mu/l
281.3
272.6
0.08
12
47
(3042936) Bacteria identified in Isolate by Culture
70
521
1.41
1.80
1.7
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
67
2.13
1.78
1.1
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
48
333
1.50
1.77
2.0
2.2
ug/g
79.3
120.0
0.94
31
254
(3021601) Nitrite [Presence] in Urine by Test strip
191
1653
1.28
1.74
4.5
5.0
estimate
0.0
0.0
0.00
43
269
(3007930) Methemoglobin/Hemoglobin.total in Blood
8
179
0.44
1.73
4.8
4.7
%
0.9
0.9
—
8
172
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
13
3.88
1.72
2.2
1.4
nmol/l
2.6
4.4
—
5
13
(3045788) Cell count panel - Pleural fluid
8
31
2.61
1.66
1.6
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
25
2.83
1.65
1.0
1.3
ug/l
14.6
15.3
—
7
25
(40768797) Stomach Pathology biopsy report
66
495
1.39
1.63
1.4
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
107
867
1.31
1.60
3.1
3.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
123
1018
1.29
1.57
3.0
3.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
21
122
1.76
1.57
3.3
2.4
g/l
0.6
0.2
—
8
36
(3023368) Bacteria identified in Blood by Culture
121
1001
1.29
1.55
5.0
3.8
—
—
—
0
0
(4034850)
6
140
0.42
1.55
3.7
10.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
15
3.36
1.52
1.0
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
51
2.19
1.51
4.0
2.0
e9/l
4.4
4.6
0.17
11
51
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
50
363
1.43
1.49
2.6
2.4
umol/l
7.7
7.3
0.06
45
319
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
36
245
1.51
1.48
1.7
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
52
2.14
1.45
4.5
2.3
%
59.9
58.0
0.25
11
52
(3019060) Gas panel - Arterial blood
16
275
0.57
1.44
2.5
4.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
9
39
2.33
1.43
5.3
1.9
u/ml
92.4
93.6
—
9
33
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
46
2.20
1.41
4.4
1.8
pg
32.7
33.4
—
10
46
(46235355) HIV 1 and 2 tests - Meaningful Use set
49
359
1.41
1.40
1.5
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
61
465
1.36
1.38
5.4
5.2
mmol/l
1.0
1.0
0.08
55
418
(4306422)
9
41
2.22
1.37
1.2
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
23
2.63
1.37
1.2
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
17
2.96
1.36
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
49
362
1.40
1.34
4.6
4.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
24
2.52
1.31
1.0
1.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
18
2.80
1.29
1.6
1.2
mmol/l
5.9
7.4
—
5
18
(3015736) pH of Urine
152
1325
1.23
1.22
2.8
3.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
37
2.18
1.22
1.6
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
19
2.65
1.22
1.2
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
94
1.73
1.19
2.4
2.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
72
577
1.30
1.18
32.9
29.8
inr
1.2
1.3
—
10
78
(3007164) IgA [Mass/volume] in Serum or Plasma
71
568
1.30
1.18
1.5
1.2
g/l
2.2
2.8
2.14
42
334
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
50
2.02
1.17
1.0
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
12
209
0.56
1.16
5.9
3.0
mmol/l
24.4
25.4
1.03
12
203
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
34
242
1.44
1.16
1.4
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
8
39
2.07
1.16
1.0
1.1
—
1.7
—
0
12
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
39
2.07
1.16
1.1
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
39
2.07
1.16
1.4
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
20
2.52
1.15
1.0
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
10
182
0.54
1.13
4.0
4.7
%
1.5
1.6
—
10
175
(3042631) Mycobacterium sp identified in Specimen
8
40
2.02
1.12
2.4
2.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
41
305
1.38
1.10
9.1
7.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
21
2.40
1.09
1.6
3.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
33
2.14
1.06
1.0
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
68
552
1.28
1.02
3.1
2.3
umol/l
12.5
13.4
0.39
63
500
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
68
1.79
1.01
1.2
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
35
2.02
1.00
2.9
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
36
1.96
0.97
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
32
234
1.40
0.97
4.1
3.7
%
0.2
0.1
—
10
49
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
51
1.78
0.95
1.3
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
146
0.54
0.94
1.3
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
25
177
1.44
0.90
3.4
3.6
mmol/l
24.1
24.5
0.20
25
160
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
114
997
1.19
0.87
1.6
1.7
mmol/l
1.3
1.3
0.43
87
819
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
12
72
1.69
0.86
1.7
2.1
pmol/l
205.0
222.8
0.41
12
67
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
22
154
1.45
0.85
2.6
2.3
ug/l
657.2
638.6
0.02
22
140
(40760892) CBC W Ordered Manual Differential panel - Blood
82
697
1.22
0.84
5.1
3.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
198
1.39
0.82
7.6
9.0
—
—
—
0
0
(1002224) Polysomnography panel
19
130
1.48
0.82
1.0
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
32
1.89
0.82
1.3
1.2
—
—
—
0
0
(4268621)
6
32
1.89
0.82
2.2
2.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
103
901
1.19
0.78
3.3
3.7
estimate
0.0
0.0
0.50
43
263
(40761535) Cells panel - Urine sediment
24
324
0.73
0.78
3.1
3.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
124
1103
1.17
0.77
3.2
2.1
u/l
58.6
57.6
0.12
109
1014
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
161
0.61
0.77
1.5
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
34
1.78
0.76
2.7
2.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
67
1.66
0.76
2.4
2.6
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
38
1.86
0.74
2.0
2.0
—
303.7
—
0
6
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
38
1.86
0.74
1.4
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
32
247
1.32
0.73
4.2
3.6
%
0.8
0.8
—
10
55
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
68
1.63
0.72
1.4
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
57
1.59
0.71
1.4
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
29
223
1.32
0.68
3.8
3.6
%
0.3
0.6
—
6
40
(3025159) Blasts/100 leukocytes in Blood
29
223
1.32
0.68
4.3
3.8
%
0.0
2.0
—
8
43
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
53
442
1.23
0.67
1.8
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
138
1252
1.15
0.66
3.3
3.0
ng/l
2172.5
1484.5
0.63
117
1067
(4062490)
5
28
1.79
0.66
1.2
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
53
443
1.22
0.65
1.8
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
62
1.63
0.65
4.8
2.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
131
0.60
0.64
1.0
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
71
613
1.19
0.63
1.7
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
49
1.64
0.62
1.5
1.5
—
—
—
0
0
(44813793)
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
20
0.00
0.60
0.0
2.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
21
0.00
0.60
0.0
2.3
—
52.2
—
0
6
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
35
1.72
0.58
1.0
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
12
172
0.69
0.57
5.9
4.3
mmol/l
24.8
25.1
0.18
12
161
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
98
1.44
0.57
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
141
1294
1.13
0.57
3.7
3.1
mmol/l
7.7
7.7
0.02
103
1083
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
203
1.30
0.57
2.7
2.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
214
1.28
0.54
2.1
1.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
91
1.44
0.53
3.2
4.1
mg/l
47.2
26.0
—
6
65
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
39
1.55
0.53
1.2
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
109
1.39
0.51
1.3
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
67
1.50
0.50
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
28
226
1.26
0.49
3.3
2.8
e9/l
4.0
4.0
0.03
18
162
(3045414) Leukocytes [Presence] in Urine
18
137
1.33
0.48
1.5
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
146
1.32
0.48
1.2
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
7
48
1.47
0.47
1.4
1.3
mmol/l
8.2
7.7
—
7
35
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
82
0.61
0.46
1.0
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
33
275
1.22
0.45
3.2
2.1
ml/min/173m2
66.6
61.9
0.33
20
107
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
17
131
1.31
0.42
1.9
1.5
—
123.3
—
0
6
(3003327) Ova and parasites identified in Stool by Light microscopy
12
87
1.39
0.42
1.8
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
5
32
1.57
0.42
3.8
3.2
%
0.4
1.2
—
5
26
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
57
1.41
0.42
1.5
2.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
33
1.52
0.41
1.2
1.3
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
15
0.00
0.41
0.0
1.1
—
231.9
—
0
8
(44806420)
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
79
1.40
0.41
1.3
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
34
1.48
0.40
1.2
1.3
pmol/l
67.8
67.7
—
5
34
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
331.2
—
0
18
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
80
726
1.13
0.40
2.9
1.7
mg/l
1.7
1.3
0.43
56
570
(3025941) Bacteria identified in Stool by Culture
20
160
1.26
0.39
1.1
1.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.8
—
0.9
—
0
12
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
19
0.00
0.39
0.0
7.2
—
42.0
—
0
5
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
105.4
—
0
14
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
67
1.35
0.38
1.6
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
48
424
1.15
0.36
1.3
1.3
titre
384.0
528.4
—
10
100
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
78
0.64
0.36
1.0
1.2
—
37.3
—
0
8
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
42
1.43
0.35
1.0
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
6
43
1.40
0.35
1.0
1.0
g/l
1.6
1.5
—
6
38
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
71
646
1.12
0.34
1.3
1.2
u/ml
1.9
1.7
0.05
23
173
(3007566) Smooth muscle Ab [Titer] in Serum
11
82
1.35
0.34
1.7
1.2
—
123.3
—
0
6
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
45
1.34
0.34
1.2
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
11
83
1.33
0.32
2.4
2.4
kpa
7.7
7.9
0.19
11
75
(3012516) Albumin [Mass/volume] in Urine
135
1274
1.09
0.32
3.9
3.2
mg/l
598.1
250.7
0.29
84
817
(3022313) Gas panel - Capillary blood
16
197
0.80
0.31
4.8
4.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
54
1.30
0.30
4.9
2.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
26
222
1.18
0.30
1.3
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
56
1.25
0.29
1.0
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
33
289
1.15
0.29
1.2
1.4
—
—
—
0
0
(3000492) Spirometry study
31
271
1.16
0.28
1.6
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
141
1341
1.08
0.28
5.2
4.0
mg/mmol
10.6
7.3
0.48
86
868
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
224
0.84
0.26
1.7
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
75
0.66
0.26
1.0
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
92
863
1.08
0.26
1.5
1.8
pmol/l
392.6
8108520.6
0.50
67
703
(3008898) HLA-B27 [Presence]
6
84
0.71
0.24
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
106
1.23
0.23
1.6
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
94
0.74
0.22
1.0
1.2
—
3.1
—
0
14
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
44
402
1.11
0.22
1.6
1.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
23
201
1.15
0.21
2.2
2.5
%
1.0
1.1
0.52
23
201
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
42
1.19
0.21
1.6
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
11.5
—
0.6
—
0
11
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
11
0.00
0.21
0.0
6.8
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
6.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
12
0.00
0.21
0.0
6.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
12
0.00
0.21
0.0
1.1
—
1.9
—
0
12
(3006576) Bicarbonate [Moles/volume] in Blood
0
12
0.00
0.21
0.0
6.4
—
26.4
—
0
12
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
12
0.00
0.21
0.0
6.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
43
1.16
0.21
1.4
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
43
1.16
0.21
1.4
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
28.2
—
0
13
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
38
417
0.90
0.21
8.1
6.3
%
96.0
95.1
0.65
38
401
(3004119) Hemoglobin [Mass/volume] in Venous blood
24
271
0.88
0.20
3.2
2.9
g/l
123.9
129.8
0.51
24
266
(3028433) Virus identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(4146454)
6
49
1.23
0.20
2.0
2.8
—
—
—
0
0
(4010399)
31
279
1.12
0.20
1.3
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
52
1.16
0.19
3.5
3.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
137
1.17
0.19
1.1
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
53
1.13
0.18
2.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
132
0.83
0.18
1.7
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
68
0.73
0.17
1.6
1.1
u/l
363.2
20.2
—
5
59
(3022621) pH of Urine by Test strip
27
244
1.11
0.16
2.1
2.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
13
150
0.86
0.15
1.7
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
43
460
0.93
0.15
7.8
6.3
mmol/l
0.1
1.4
1.71
34
351
(3006184) Hemoglobin [Mass/volume] in Capillary blood
9
83
1.09
0.14
2.4
1.9
g/l
135.3
130.6
—
9
61
(3039443) Prostate specific Ag panel - Serum or Plasma
9
83
1.09
0.14
1.3
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
96
0.83
0.14
2.3
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
97
0.82
0.14
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
97
0.82
0.14
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
100
0.80
0.13
1.0
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
24
263
0.91
0.13
4.1
3.7
kpa
5.2
5.2
0.04
24
243
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
52
548
0.94
0.12
1.2
1.3
u/ml
3.3
11.8
1.70
15
197
(3011397) Hemoglobin [Presence] in Urine by Test strip
84
810
1.05
0.11
3.0
3.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
48
505
0.94
0.11
5.3
7.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
156
0.89
0.10
1.6
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
46
1.09
0.09
1.4
1.2
nmol/l
0.7
0.5
—
5
40
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
47
1.06
0.09
1.0
1.1
—
19.2
—
0
12
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
130
1272
1.03
0.09
3.4
3.9
—
—
—
0
0
(3009343) pH of Capillary blood
24
257
0.93
0.08
4.1
3.8
ph
7.4
7.4
—
5
25
(1761482) Bacteria [#/volume] in Urine by Culture
10
113
0.88
0.08
3.8
4.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
68
1.03
0.08
1.3
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
60
580
1.04
0.07
1.2
1.3
iu/ml
35.1
38.0
0.06
18
178
(3014051) Protein [Presence] in Urine by Test strip
8
76
1.05
0.07
1.6
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
76
1.05
0.07
1.1
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
7
82
0.85
0.07
1.7
2.0
mg/l
9.8
12.9
—
7
75
(4094501)
9
104
0.86
0.06
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
18
192
0.93
0.05
1.6
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
21
222
0.94
0.05
1.3
1.4
—
50.4
—
0
11
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
121
1.08
0.03
6.5
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
35
339
1.04
0.03
1.7
1.8
%
2.0
1.7
0.61
30
285
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
39
379
1.03
0.03
1.5
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
21
219
0.96
0.03
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
19
197
0.96
0.01
3.4
3.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
153
1538
0.99
0.01
3.4
3.9
ng/l
43.7
67.7
0.50
112
1143
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
40
406
0.98
0.00
1.5
2.5
ug/l
9.0
7.3
0.26
33
347
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
153
0.98
0.00
1.9
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
25
252
0.99
0.00
2.4
2.5
—
15.3
—
0
7
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
60
1.00
0.00
2.7
2.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.8
—
0
5
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
100.5
—
0
8
(3041354) Potassium [Moles/volume] in Venous blood
6
62
0.97
0.00
2.7
2.6
mmol/l
3.9
4.1
—
6
62
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
78
0.90
0.00
1.4
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
50
1.00
0.00
1.4
1.6
%
89.1
90.4
—
5
50
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
1.8
—
0
6
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
5.7
—
6.4
—
0
7
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(4198724)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.7
—
5.6
—
0
7
(3035285) Chloride [Moles/volume] in Venous blood
6
62
0.97
0.00
2.7
2.6
mmol/l
106.2
104.8
—
6
62
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
94
0.96
0.00
1.7
1.7
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
62
0.97
0.00
1.0
1.3
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
67
0.89
0.00
1.0
1.3
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
38.6
—
0
7
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
68
0.88
0.00
1.2
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_TRUNK_EXALLC – Melanoma in situ of trunk
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).